|
1
|
Brandao GD, Brega EF and Spatz A: The role
of molecular pathology in non-small-cell lung carcinoma-now and in
the future. Curr Oncol. 19(Suppl 1): S24–S32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2014. Ann Oncol. 25:1650–1656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jethon A, Pula B, Olbromski M, Werynska B,
Muszczynska- Bernhard B, Witkiewicz W, Dziegiel P and
Podhorska-Okolow M: Prognostic significance of SOX18 expression in
non-small cell lung cancer. Int J Oncol. 46:123–132. 2015.
|
|
4
|
Gubbay J, Collignon J, Koopman P, Capel B,
Economou A, Münsterberg A, Vivian N, Goodfellow P and Lovell-Badge
R: A gene mapping to the sex-determining region of the mouse Y
chromosome is a member of a novel family of embryonically expressed
genes. Nature. 346:245–250. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu Y, Li Y, Jun Wei JW and Liu X: The
role of Sox genes in lung morphogenesis and cancer. Int J Mol Sci.
13:15767–15783. 2012. View Article : Google Scholar
|
|
6
|
Wegner M: From head to toes: The multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taniguchi K, Hiraoka Y, Ogawa M, Sakai Y,
Kido S and Aiso S: Isolation and characterization of a mouse
SRY-related cDNA, mSox7. Biochim Biophys Acta. 1445:225–231. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanai Y, Kanai-Azuma M, Noce T, Saido TC,
Shiroishi T, Hayashi Y and Yazaki K: Identification of two Sox17
messenger RNA isoforms, with and without the high mobility group
box region, and their differential expression in mouse
spermato-genesis. J Cell Biol. 133:667–681. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dunn TL, Mynett-Johnson L, Wright EM,
Hosking BM, Koopman PA and Muscat GE: Sequence and expression of
Sox-18 encoding a new HMG-box transcription factor. Gene.
161:223–225. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cermenati S, Moleri S, Cimbro S, Corti P,
Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F and Beltrame
M: Sox18 and Sox7 play redundant roles in vascular development.
Blood. 111:2657–2666. 2008. View Article : Google Scholar
|
|
12
|
Cermenati S, Moleri S, Neyt C, Bresciani
E, Carra S, Grassini DR, Omini A, Goi M, Cotelli F, François M, et
al: Sox18 genetically interacts with VegfC to regulate
lymphangiogenesis in zebrafish. Arterioscler Thromb Vasc Biol.
33:1238–1247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Downes M, François M, Ferguson C, Parton
RG and Koopman P: Vascular defects in a mouse model of
hypotrichosis-lymphedema-telangiectasia syndrome indicate a role
for SOX18 in blood vessel maturation. Hum Mol Genet. 18:2839–2850.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
François M, Caprini A, Hosking B, Orsenigo
F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M,
et al: Sox18 induces development of the lymphatic vasculature in
mice. Nature. 456:643–647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pendeville H, Winandy M, Manfroid I,
Nivelles O, Motte P, Pasque V, Peers B, Struman I, Martial JA and
Voz ML: Zebrafish Sox7 and Sox18 function together to control
arterial-venous identity. Dev Biol. 317:405–416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pula B, Olbromski M, Wojnar A,
Gomulkiewicz A, Witkiewicz W, Ugorski M, Dziegiel P and
Podhorska-Okolow M: Impact of SOX18 expression in cancer cells and
vessels on the outcome of invasive ductal breast carcinoma. Cell
Oncol (Dordr). 36:469–483. 2013. View Article : Google Scholar
|
|
17
|
Young N, Hahn CN, Poh A, Dong C, Wilhelm
D, Olsson J, Muscat GE, Parsons P, Gamble JR and Koopman P: Effect
of disrupted SOX18 transcription factor function on tumor growth,
vascularization, and endothelial development. J Natl Cancer Inst.
98:1060–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duong T, Proulx ST, Luciani P, Leroux JC,
Detmar M, Koopman P and Francois M: Genetic ablation of SOX18
function suppresses tumor lymphangiogenesis and metastasis of
melanoma in mice. Cancer Res. 72:3105–3114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang G, Wei Z, Jia H, Zhao W, Yang G and
Zhao H: Knockdown of SOX18 inhibits the proliferation, migration
and invasion of hepatocellular carcinoma cells. Oncol Rep.
34:1121–1128. 2015.PubMed/NCBI
|
|
20
|
Petrovic I, Milivojevic M, Popovic J,
Schwirtlich M, Rankovic B and Stevanovic M: SOX18 is a novel target
gene of Hedgehog signaling in cervical carcinoma cell line. PLoS
One. 10:e01435912015. View Article : Google Scholar
|
|
21
|
Zhang J, Ma Y, Wang S, Chen F and Gu Y:
Suppression of SOX18 by siRNA inhibits cell growth and invasion of
breast cancer cells. Oncol Rep. 35:3721–3727. 2016.PubMed/NCBI
|
|
22
|
Majid S, Dar AA, Saini S, Shahryari V,
Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, et
al: miRNA-34b inhibits prostate cancer through demethylation,
active chromatin modifications, and AKT pathways. Clin Cancer Res.
19:73–84. 2013. View Article : Google Scholar
|
|
23
|
Devaraj S and Natarajan J: miRNA-mRNA
network detects hub mRNAs and cancer specific miRNAs in lung
cancer. In Silico Biol. 11:281–295. 2012.PubMed/NCBI
|
|
24
|
Lin PY and Yang PC: Circulating miRNA
signature for early diagnosis of lung cancer. EMBO Mol Med.
3:436–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang C, Hu X, Alattar M and Zhao H: miRNA
expression profiles associated with diagnosis and prognosis in lung
cancer. Expert Rev Anticancer Ther. 14:453–461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lv J and Xu L, Xu Y, Qiu M, Yang X, Wang
J, Yin R and Xu L: Expression of miRNA-221 in non-small cell lung
cancer tissues and correlation with prognosis. Zhongguo Fei Ai Za
Zhi. 17:221–225. 2014.In Chinese. PubMed/NCBI
|
|
29
|
Mairinger FD, Ting S, Werner R, Walter RF,
Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T,
Sheu-Grabellus SY, et al: Different micro-RNA expression profiles
distinguish subtypes of neuroendocrine tumors of the lung: Results
of a profiling study. Mod Pathol. 27:1632–1640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salim H, Arvanitis A, de Petris L, Kanter
L, Hååg P, Zovko A, Özata DM, Lui WO, Lundholm L, Zhivotovsky B, et
al: miRNA-214 is related to invasiveness of human non-small cell
lung cancer and directly regulates alpha protein kinase 2
expression. Genes Chromosomes Cancer. 52:895–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lang Y, Xu S, Ma J, Wu J, Jin S, Cao S and
Yu Y: MicroRNA-429 induces tumorigenesis of human non-small cell
lung cancer cells and targets multiple tumor suppressor genes.
Biochem Biophys Res Commun. 450:154–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lovell-Badge R: The early history of the
Sox genes. Int J Biochem Cell Biol. 42:378–380. 2010. View Article : Google Scholar
|
|
34
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: Biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Azhikina T, Kozlova A, Skvortsov T and
Sverdlov E: Heterogeneity and degree of TIMP4, GATA4, SOX18, and
EGFL7 gene promoter methylation in non-small cell lung cancer and
surrounding tissues. Cancer Genet. 204:492–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dammann R, Strunnikova M, Schagdarsurengin
U, Rastetter M, Papritz M, Hattenhorst UE, Hofmann HS, Silber RE,
Burdach S and Hansen G: CpG island methylation and expression of
tumour-associated genes in lung carcinoma. Eur J Cancer.
41:1223–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Balakrishnan I, Yang X, Brown J,
Ramakrishnan A, Torok-Storb B, Kabos P, Hesselberth JR and Pillai
MM: Genome-wide analysis of miRNA-mRNA interactions in marrow
stromal cells. Stem Cells. 32:662–673. 2014. View Article : Google Scholar :
|
|
38
|
Crémazy F, Berta P and Girard F:
Genome-wide analysis of Sox genes in Drosophila melanogaster. Mech
Dev. 109:371–375. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu D, Krueger J and Le Noble F: The role
of blood flow and microRNAs in blood vessel development. Int J Dev
Biol. 55:419–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sen CK, Gordillo GM, Khanna S and Roy S:
Micromanaging vascular biology: Tiny microRNAs play big band. J
Vasc Res. 46:527–540. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sarkar A and Hochedlinger K: The sox
family of transcription factors: Versatile regulators of stem and
progenitor cell fate. Cell Stem Cell. 12:15–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thu KL, Becker-Santos DD, Radulovich N,
Pikor LA, Lam WL and Tsao MS: SOX15 and other SOX family members
are important mediators of tumorigenesis in multiple cancer types.
Oncoscience. 1:326–335. 2014. View Article : Google Scholar
|
|
43
|
Xie C, Han Y, Liu Y, Han L and Liu J:
miRNA-124 down-regulates SOX8 expression and suppresses cell
proliferation in non-small cell lung cancer. Int J Clin Exp Pathol.
7:7518–7526. 2014.
|
|
44
|
Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F,
Bao G, Kong H, Ge C, Zhang F, et al: miRNA-200c inhibits invasion
and metastasis of human non-small cell lung cancer by directly
targeting ubiquitin specific peptidase 25. Mol Cancer. 13:1662014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Salim H, Akbar NS, Zong D, Vaculova AH,
Lewensohn R, Moshfegh A, Viktorsson K and Zhivotovsky B: miRNA-214
modulates radiotherapy response of non-small cell lung cancer cells
through regulation of p38MAPK, apoptosis and senescence. Br J
Cancer. 107:1361–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang C, Ge S, Hu C, Yang N and Zhang J:
MiRNA-218, a new regulator of HMGB1, suppresses cell migration and
invasion in non-small cell lung cancer. Acta Biochim Biophys Sin
(Shanghai). 45:1055–1061. 2013. View Article : Google Scholar
|
|
47
|
Li J, Zheng Y, Sun G and Xiong S:
Restoration of miR-7 expression suppresses the growth of Lewis lung
cancer cells by modulating epidermal growth factor receptor
signaling. Oncol Rep. 32:2511–2516. 2014.PubMed/NCBI
|
|
48
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mei S, Liu Y, Bao Y, Zhang Y, Min S, Liu
Y, Huang Y, Yuan X, Feng Y, Shi J, et al: Dendritic cell-associated
miRNAs are modulated via chromatin remodeling in response to
different environments. PLoS One. 9:e902312014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Brock M, Samillan VJ, Trenkmann M,
Schwarzwald C, Ulrich S, Gay RE, Gassmann M, Ostergaard L, Gay S,
Speich R, et al: AntagomiR directed against miR-20a restores
functional BMPR2 signalling and prevents vascular remodelling in
hypoxia-induced pulmonary hypertension. Eur Heart J. 35:3203–3211.
2014. View Article : Google Scholar
|
|
51
|
Li J, Bai H, Zhu Y, Wang XY, Wang F, Zhang
JW, Lavker RM and Yu J: Antagomir dependent microRNA-205 reduction
enhances adhesion ability of human corneal epithelial
keratinocytes. Chin Med Sci J. 25:65–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu D, Huang Y, Jia C, Li Y, Liang F and
Fu Q: Administration of antagomir-223 inhibits apoptosis, promotes
angiogenesis and functional recovery in rats with spinal cord
injury. Cell Mol Neurobiol. 35:483–491. 2015. View Article : Google Scholar
|
|
53
|
Selvamani A, Sathyan P, Miranda RC and
Sohrabji F: An antagomir to microRNA Let7f promotes neuroprotection
in an ischemic stroke model. PLoS One. 7:e326622012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Song MS and Rossi JJ: The anti-miR21
antagomir, a therapeutic tool for colorectal cancer, has a
potential synergistic effect by perturbing an
angiogenesis-associated miR30. Front Genet. 4:3012014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sun B, Yang N, Jiang Y, Zhang H, Hou C, Ji
C, Liu Y and Zuo P: Antagomir-1290 suppresses CD133+
cells in non-small cell lung cancer by targeting fyn-related Src
family tyrosine kinase. Tumour Biol. 36:6223–6230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Faghihi MA, Zhang M, Huang J, Modarresi F,
Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G III and
Wahlestedt C: Evidence for natural antisense transcript-mediated
inhibition of microRNA function. Genome Biol. 11:R562010.
View Article : Google Scholar : PubMed/NCBI
|
